A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples based on distinct molecular features identified by The Cancer Genome Atlas (TCGA) Network. The resource comprises classifier models that can accelerate the design of cancer subtype-specific test kits for use in clinical trials and cancer diagnosis. This is an important advance because tumors belonging to different subtypes may vary in their response to cancer therapies.